chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hot to Touch Sensation - Near Injection Site; Itchy Sensation - Near Injection Site; Arm Pain - Near Injection Site; Swelling - Near Injection Site; Rash - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to Touch Sensation - Near Injection Site), VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE PAIN (Arm Pain - Near Injection Site), VACCINATION SITE SWELLING (Swelling - Near Injection Site) and VACCINATION SITE RASH (Rash - Near Injection Site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot to Touch Sensation - Near Injection Site), VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE PAIN (Arm Pain - Near Injection Site), VACCINATION SITE SWELLING (Swelling - Near Injection Site) and VACCINATION SITE RASH (Rash - Near Injection Site). At the time of the report, VACCINATION SITE WARMTH (Hot to Touch Sensation - Near Injection Site), VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE PAIN (Arm Pain - Near Injection Site), VACCINATION SITE SWELLING (Swelling - Near Injection Site) and VACCINATION SITE RASH (Rash - Near Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided  by the reporter.  Treatment information was not provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Paraesthesia, Pyrexia, Urinary tract infection
Clinical narrative: Patient feels "needles"; UTI symptoms; muscle pain; fatigue; fever; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Patient feels "needles"), URINARY TRACT INFECTION (UTI symptoms), MYALGIA (muscle pain), FATIGUE (fatigue) and PYREXIA (fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced MYALGIA (muscle pain), FATIGUE (fatigue) and PYREXIA (fever). On 10-Feb-2021, the patient experienced PARAESTHESIA (Patient feels "needles") and URINARY TRACT INFECTION (UTI symptoms). On 08-Feb-2021, MYALGIA (muscle pain) and FATIGUE (fatigue) had resolved. At the time of the report, PARAESTHESIA (Patient feels "needles"), URINARY TRACT INFECTION (UTI symptoms) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Pain in extremity, Stomach mass
Clinical narrative: pain in back of legs and arms; fatigue; diarrhea; knot in my stomach; This spontaneous case was reported by a consumer and describes the occurrence of STOMACH MASS (knot in my stomach), DIARRHOEA (diarrhea), FATIGUE (fatigue) and PAIN IN EXTREMITY (pain in back of legs and arms) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced STOMACH MASS (knot in my stomach). On 03-Feb-2021, the patient experienced DIARRHOEA (diarrhea) and FATIGUE (fatigue). On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in back of legs and arms). On 06-Feb-2021, PAIN IN EXTREMITY (pain in back of legs and arms) had resolved. At the time of the report, STOMACH MASS (knot in my stomach), DIARRHOEA (diarrhea) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: warmness; Hardness; Redness; Itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warmness), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PRURITUS (Itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L202) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warmness), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PRURITUS (Itchy). On 28-Jan-2021, VACCINATION SITE WARMTH (warmness), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PRURITUS (Itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment details included Ice packs.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling
Clinical narrative: severe swelling in the arm; redness; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (severe swelling in the arm) and ERYTHEMA (redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (severe swelling in the arm) and ERYTHEMA (redness). At the time of the report, PERIPHERAL SWELLING (severe swelling in the arm) and ERYTHEMA (redness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided. Patient reports that HCP recommended that the patient should not take the second vaccine.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pyrexia
Clinical narrative: body temperature went up; Joints ache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (body temperature went up) and ARTHRALGIA (Joints ache) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PYREXIA (body temperature went up) and ARTHRALGIA (Joints ache). At the time of the report, PYREXIA (body temperature went up) and ARTHRALGIA (Joints ache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea
Clinical narrative: Headache; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.            No concomitant product use was reported
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pyrexia, Vaccination site discolouration, Vaccination site erythema, Vaccination site pain
Clinical narrative: warm at site of injection; the center of it looks kind of yellow; arm itching; pinkish-red arm of injection; bigger; cold symptoms; tender site of injection/soreness; feverish 99.9F; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (tender site of injection/soreness), PYREXIA (feverish 99.9F), NASOPHARYNGITIS (cold symptoms), VACCINATION SITE PRURITUS (arm itching) and VACCINATION SITE ERYTHEMA (pinkish-red arm of injection) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (anti-inflammatories), Sulfonamide allergy (sulfur), Drug allergy (codeine), Allergy to antibiotic (minocycline) and Shellfish allergy. Concomitant products included CALCIUM, VITAMIN D [VITAMIN D NOS], TOCOPHEROL (VITAMIN E [TOCOPHEROL]), PROBIOTICS NOS, ACETYLSALICYLIC ACID (BABY ASPIRIN), PROSTATINE and medicine for allergies for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (tender site of injection/soreness) and PYREXIA (feverish 99.9F). On 03-Feb-2021, the patient experienced NASOPHARYNGITIS (cold symptoms). On 09-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (arm itching), VACCINATION SITE ERYTHEMA (pinkish-red arm of injection), VACCINATION SITE WARMTH (warm at site of injection), VACCINATION SITE SWELLING (bigger) and VACCINATION SITE DISCOLOURATION (the center of it looks kind of yellow). The patient was treated with PARACETAMOL (TYLENOL) for Cold symptoms, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (tender site of injection/soreness), PYREXIA (feverish 99.9F), NASOPHARYNGITIS (cold symptoms), VACCINATION SITE PRURITUS (arm itching), VACCINATION SITE ERYTHEMA (pinkish-red arm of injection), VACCINATION SITE WARMTH (warm at site of injection), VACCINATION SITE SWELLING (bigger) and VACCINATION SITE DISCOLOURATION (the center of it looks kind of yellow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: warm at site of injection; the center of it looks kind of yellow; arm itching; pinkish-red arm of injection; bigger; cold symptoms; tender site of injection/soreness; feverish 99.9F; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (tender site of injection/soreness), PYREXIA (feverish 99.9F), NASOPHARYNGITIS (cold symptoms), VACCINATION SITE PRURITUS (arm itching) and VACCINATION SITE ERYTHEMA (pinkish-red arm of injection) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (anti-inflammatories), Sulfonamide allergy (sulfur), Drug allergy (codeine), Allergy to antibiotic (minocycline) and Shellfish allergy. Concomitant products included CALCIUM, VITAMIN D [VITAMIN D NOS], TOCOPHEROL (VITAMIN E [TOCOPHEROL]), PROBIOTICS NOS, ACETYLSALICYLIC ACID (BABY ASPIRIN), PROSTATINE and medicine for allergies for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (tender site of injection/soreness) and PYREXIA (feverish 99.9F). On 03-Feb-2021, the patient experienced NASOPHARYNGITIS (cold symptoms). On 09-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (arm itching), VACCINATION SITE ERYTHEMA (pinkish-red arm of injection), VACCINATION SITE WARMTH (warm at site of injection), VACCINATION SITE SWELLING (bigger) and VACCINATION SITE DISCOLOURATION (the center of it looks kind of yellow). The patient was treated with PARACETAMOL (TYLENOL) for Cold symptoms, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (tender site of injection/soreness), PYREXIA (feverish 99.9F), NASOPHARYNGITIS (cold symptoms), VACCINATION SITE PRURITUS (arm itching), VACCINATION SITE ERYTHEMA (pinkish-red arm of injection), VACCINATION SITE WARMTH (warm at site of injection), VACCINATION SITE SWELLING (bigger) and VACCINATION SITE DISCOLOURATION (the center of it looks kind of yellow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: tested positive after receiving first dose of vaccine; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive after receiving first dose of vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (tested positive after receiving first dose of vaccine). At the time of the report, COVID-19 (tested positive after receiving first dose of vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Caregiver reports that patient got the 1st dose about a month prior to event. No treatment information was provided.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for covid). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for covid) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, SARS-CoV-2 test positive: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medication reported. patient was administered with second dose.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Follow up received updated outcome of the event.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Insomnia, Myalgia, Pyrexia
Clinical narrative: Felt restless; Having trouble sleeping; High fever of 101°F - 103°F; Chills; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of RESTLESSNESS (Felt restless), INSOMNIA (Having trouble sleeping), PYREXIA (High fever of 101°F - 103°F), CHILLS (Chills) and MYALGIA (Body ache) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced RESTLESSNESS (Felt restless), INSOMNIA (Having trouble sleeping), PYREXIA (High fever of 101°F - 103°F), CHILLS (Chills) and MYALGIA (Body ache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, RESTLESSNESS (Felt restless), INSOMNIA (Having trouble sleeping), PYREXIA (High fever of 101°F - 103°F), CHILLS (Chills) and MYALGIA (Body ache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: 101°f - 103°f 101°F - 103°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications include blood pressure, thyroid, prostate and statins
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Restlessness
Clinical narrative: Felt restless; Having trouble sleeping; High fever of 101°F - 103°F; Chills; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of RESTLESSNESS (Felt restless), INSOMNIA (Having trouble sleeping), PYREXIA (High fever of 101°F - 103°F), CHILLS (Chills) and MYALGIA (Body ache) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced RESTLESSNESS (Felt restless), INSOMNIA (Having trouble sleeping), PYREXIA (High fever of 101°F - 103°F), CHILLS (Chills) and MYALGIA (Body ache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, RESTLESSNESS (Felt restless), INSOMNIA (Having trouble sleeping), PYREXIA (High fever of 101°F - 103°F), CHILLS (Chills) and MYALGIA (Body ache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: 101°f - 103°f 101°F - 103°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications include blood pressure, thyroid, prostate and statins
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Feeling abnormal, Insomnia, Lethargy
Clinical narrative: can barely move arm; feels really lethargic; she could taste the vaccine in her mouth within a minute; weak with chills.; very achy; felt a bit weird; weak; could not sleep; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt a bit weird), ASTHENIA (weak), INSOMNIA (could not sleep), MOBILITY DECREASED (can barely move arm) and LETHARGY (feels really lethargic) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sulfonamide allergy (sulfa drugs) and Drug allergy (codeine).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced FEELING ABNORMAL (felt a bit weird), ASTHENIA (weak), INSOMNIA (could not sleep), TASTE DISORDER (she could taste the vaccine in her mouth within a minute), CHILLS (weak with chills.) and MYALGIA (very achy). On 11-Feb-2021, the patient experienced MOBILITY DECREASED (can barely move arm) and LETHARGY (feels really lethargic). At the time of the report, FEELING ABNORMAL (felt a bit weird), ASTHENIA (weak), INSOMNIA (could not sleep), MOBILITY DECREASED (can barely move arm), LETHARGY (feels really lethargic), TASTE DISORDER (she could taste the vaccine in her mouth within a minute), CHILLS (weak with chills.) and MYALGIA (very achy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Myalgia, Taste disorder
Clinical narrative: can barely move arm; feels really lethargic; she could taste the vaccine in her mouth within a minute; weak with chills.; very achy; felt a bit weird; weak; could not sleep; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt a bit weird), ASTHENIA (weak), INSOMNIA (could not sleep), MOBILITY DECREASED (can barely move arm) and LETHARGY (feels really lethargic) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sulfonamide allergy (sulfa drugs) and Drug allergy (codeine).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced FEELING ABNORMAL (felt a bit weird), ASTHENIA (weak), INSOMNIA (could not sleep), TASTE DISORDER (she could taste the vaccine in her mouth within a minute), CHILLS (weak with chills.) and MYALGIA (very achy). On 11-Feb-2021, the patient experienced MOBILITY DECREASED (can barely move arm) and LETHARGY (feels really lethargic). At the time of the report, FEELING ABNORMAL (felt a bit weird), ASTHENIA (weak), INSOMNIA (could not sleep), MOBILITY DECREASED (can barely move arm), LETHARGY (feels really lethargic), TASTE DISORDER (she could taste the vaccine in her mouth within a minute), CHILLS (weak with chills.) and MYALGIA (very achy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis
Clinical narrative: neck arthritis is really bothering her; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (neck arthritis is really bothering her) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer. Concurrent medical conditions included Hypertension and Arthritis. Concomitant products included PARACETAMOL (TYLENOL) for Arthritis, METOPROLOL for Hypertension.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced ARTHRITIS (neck arthritis is really bothering her). At the time of the report, ARTHRITIS (neck arthritis is really bothering her) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Paraesthesia oral, Vaccination site pain
Clinical narrative: Felt tingling in the left side of my face; felt tingling in my tongue and the left side of my face; My arm was also very sore; A spontaneous report was received from a consumer concerning a 66-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced facial paresthesia, tongue paraesthesia and vaccination site pain.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 12th Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 12 Jan 2021, 15 seconds after the vaccination, the patient experienced the events in my tongue and the left side of my face, and her arm was also felt sore.  Treatment options included Benadryl.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, experienced facial paresthesia, tongue paraesthesia and vaccination site pain, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea). At the time of the report, NAUSEA (Nausea) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.    Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event of nausea, a causal relationship cannot be excluded.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: slight headache; arm hurt off and on; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (slight headache) and PAIN IN EXTREMITY (arm hurt off and on) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: TYLENOL (Took Tylenol 500mg).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced HEADACHE (slight headache) and PAIN IN EXTREMITY (arm hurt off and on). At the time of the report, HEADACHE (slight headache) and PAIN IN EXTREMITY (arm hurt off and on) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment and concomitant medications were not provided by reporter.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Chest X-ray, Electrocardiogram, Fatigue, Feeling abnormal
Clinical narrative: He was sweating; Felt like he was hit by 2 by 4; Felt tired; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (He was sweating), FEELING ABNORMAL (Felt like he was hit by 2 by 4) and FATIGUE (Felt tired) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced HYPERHIDROSIS (He was sweating), FEELING ABNORMAL (Felt like he was hit by 2 by 4) and FATIGUE (Felt tired). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and SOTALOL for Heart rate high, at a dose of 40 mg. At the time of the report, HYPERHIDROSIS (He was sweating), FEELING ABNORMAL (Felt like he was hit by 2 by 4) and FATIGUE (Felt tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Blood test: unknown (Inconclusive) unknown. On 26-Feb-2021, Chest X-ray: inconclusive (Inconclusive) Inconclusive. On 26-Feb-2021, Electrocardiogram: inconclusive (Inconclusive) Inconclusive. On 26-Feb-2021, Heart rate: 126 (abnormal) went up to 126 and high (High) Only lasted about 5-7 hours.         No concomitant medications were reported. Patient was on heart monitor for two weeks.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Follow-up received updated event outcome and treatment dosage details.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate, Hyperhidrosis
Clinical narrative: He was sweating; Felt like he was hit by 2 by 4; Felt tired; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (He was sweating), FEELING ABNORMAL (Felt like he was hit by 2 by 4) and FATIGUE (Felt tired) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced HYPERHIDROSIS (He was sweating), FEELING ABNORMAL (Felt like he was hit by 2 by 4) and FATIGUE (Felt tired). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and SOTALOL for Heart rate high, at a dose of 40 mg. At the time of the report, HYPERHIDROSIS (He was sweating), FEELING ABNORMAL (Felt like he was hit by 2 by 4) and FATIGUE (Felt tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Blood test: unknown (Inconclusive) unknown. On 26-Feb-2021, Chest X-ray: inconclusive (Inconclusive) Inconclusive. On 26-Feb-2021, Electrocardiogram: inconclusive (Inconclusive) Inconclusive. On 26-Feb-2021, Heart rate: 126 (abnormal) went up to 126 and high (High) Only lasted about 5-7 hours.         No concomitant medications were reported. Patient was on heart monitor for two weeks.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Follow-up received updated event outcome and treatment dosage details.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Headache, Malaise, Pain, Pain in extremity
Clinical narrative: Sore arm for a couple days; Not feeling well/malaise/overall not feeing well; Localized reaction; Severe headache; Body aches; Significant amount of redness; Swelling; Arm felt itchy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm for a couple days), MALAISE (Not feeling well/malaise/overall not feeing well), PRURITUS (Arm felt itchy), VACCINATION SITE REACTION (Localized reaction) and ERYTHEMA (Significant amount of redness) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PRURITUS (Arm felt itchy), ERYTHEMA (Significant amount of redness) and SWELLING (Swelling). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm for a couple days), MALAISE (Not feeling well/malaise/overall not feeing well), VACCINATION SITE REACTION (Localized reaction), HEADACHE (Severe headache) and PAIN (Body aches). At the time of the report, PAIN IN EXTREMITY (Sore arm for a couple days), MALAISE (Not feeling well/malaise/overall not feeing well), PRURITUS (Arm felt itchy), VACCINATION SITE REACTION (Localized reaction), ERYTHEMA (Significant amount of redness), SWELLING (Swelling), HEADACHE (Severe headache) and PAIN (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medications were not provided by reporter.   This case was linked to MOD-2021-031347 (E2B Linked Report).; Sender's Comments:  MOD-2021-031347:Babycase
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Swelling, Vaccination site reaction
Clinical narrative: Sore arm for a couple days; Not feeling well/malaise/overall not feeing well; Localized reaction; Severe headache; Body aches; Significant amount of redness; Swelling; Arm felt itchy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm for a couple days), MALAISE (Not feeling well/malaise/overall not feeing well), PRURITUS (Arm felt itchy), VACCINATION SITE REACTION (Localized reaction) and ERYTHEMA (Significant amount of redness) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PRURITUS (Arm felt itchy), ERYTHEMA (Significant amount of redness) and SWELLING (Swelling). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm for a couple days), MALAISE (Not feeling well/malaise/overall not feeing well), VACCINATION SITE REACTION (Localized reaction), HEADACHE (Severe headache) and PAIN (Body aches). At the time of the report, PAIN IN EXTREMITY (Sore arm for a couple days), MALAISE (Not feeling well/malaise/overall not feeing well), PRURITUS (Arm felt itchy), VACCINATION SITE REACTION (Localized reaction), ERYTHEMA (Significant amount of redness), SWELLING (Swelling), HEADACHE (Severe headache) and PAIN (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medications were not provided by reporter.   This case was linked to MOD-2021-031347 (E2B Linked Report).; Sender's Comments:  MOD-2021-031347:Babycase
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: fever; chills; body aches; tired; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills), MYALGIA (body aches) and FATIGUE (tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced PYREXIA (fever), CHILLS (chills), MYALGIA (body aches) and FATIGUE (tired). On 05-Feb-2021, PYREXIA (fever), CHILLS (chills), MYALGIA (body aches) and FATIGUE (tired) had resolved. Not Provided          Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events,   a causal relationship cannot be excluded.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Blister, Chills, Fatigue, Lip blister
Clinical narrative: Blister under her bottom lip; Blister on her tongue; Fever; Chills; Stayed in bed all day; Feeling very tired; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (Stayed in bed all day), LIP BLISTER (Blister under her bottom lip), BLISTER (Blister on her tongue), FATIGUE (Feeling very tired) and PYREXIA (Fever) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced FATIGUE (Feeling very tired). On 27-Feb-2021, the patient experienced BEDRIDDEN (Stayed in bed all day), PYREXIA (Fever) and CHILLS (Chills). On 28-Feb-2021, the patient experienced LIP BLISTER (Blister under her bottom lip) and BLISTER (Blister on her tongue). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, BEDRIDDEN (Stayed in bed all day), LIP BLISTER (Blister under her bottom lip), BLISTER (Blister on her tongue), FATIGUE (Feeling very tired), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Blister under her bottom lip; Blister on her tongue; Fever; Chills; Stayed in bed all day; Feeling very tired; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (Stayed in bed all day), LIP BLISTER (Blister under her bottom lip), BLISTER (Blister on her tongue), FATIGUE (Feeling very tired) and PYREXIA (Fever) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced FATIGUE (Feeling very tired). On 27-Feb-2021, the patient experienced BEDRIDDEN (Stayed in bed all day), PYREXIA (Fever) and CHILLS (Chills). On 28-Feb-2021, the patient experienced LIP BLISTER (Blister under her bottom lip) and BLISTER (Blister on her tongue). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, BEDRIDDEN (Stayed in bed all day), LIP BLISTER (Blister under her bottom lip), BLISTER (Blister on her tongue), FATIGUE (Feeling very tired), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Hyperhidrosis, Myalgia, Pyrexia
Clinical narrative: sweat; aches in her whole body; a very ugly thing on her head, a discomfort on her head; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweat), MYALGIA (aches in her whole body), HEAD DISCOMFORT (a very ugly thing on her head, a discomfort on her head) and PYREXIA (low grade fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included INSULIN, METFORMIN and VITAMINS NOS for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced HYPERHIDROSIS (sweat), MYALGIA (aches in her whole body), HEAD DISCOMFORT (a very ugly thing on her head, a discomfort on her head) and PYREXIA (low grade fever). At the time of the report, HYPERHIDROSIS (sweat), MYALGIA (aches in her whole body), HEAD DISCOMFORT (a very ugly thing on her head, a discomfort on her head) and PYREXIA (low grade fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Muscular weakness, Nausea
Clinical narrative: When she tried to get out of bed her legs would not hold her up; Weakness; Very dizzy; Shaking; Severe reaction; Fever (not measured).; Chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (When she tried to get out of bed her legs would not hold her up), ASTHENIA (Weakness), DIZZINESS (Very dizzy), TREMOR (Shaking) and VACCINATION COMPLICATION (Severe reaction) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (COVID-19 Positive had COVID-19 Disease in August2020 and was Hospitalized.) in August 2020.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced MUSCULAR WEAKNESS (When she tried to get out of bed her legs would not hold her up), ASTHENIA (Weakness), DIZZINESS (Very dizzy), TREMOR (Shaking), VACCINATION COMPLICATION (Severe reaction), PYREXIA (Fever (not measured).), CHILLS (Chills) and NAUSEA (nausea). On 23-Feb-2021, MUSCULAR WEAKNESS (When she tried to get out of bed her legs would not hold her up), ASTHENIA (Weakness), DIZZINESS (Very dizzy), TREMOR (Shaking), VACCINATION COMPLICATION (Severe reaction), PYREXIA (Fever (not measured).), CHILLS (Chills) and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported Treatment medications were not reported
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tremor, Vaccination complication
Clinical narrative: When she tried to get out of bed her legs would not hold her up; Weakness; Very dizzy; Shaking; Severe reaction; Fever (not measured).; Chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (When she tried to get out of bed her legs would not hold her up), ASTHENIA (Weakness), DIZZINESS (Very dizzy), TREMOR (Shaking) and VACCINATION COMPLICATION (Severe reaction) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (COVID-19 Positive had COVID-19 Disease in August2020 and was Hospitalized.) in August 2020.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced MUSCULAR WEAKNESS (When she tried to get out of bed her legs would not hold her up), ASTHENIA (Weakness), DIZZINESS (Very dizzy), TREMOR (Shaking), VACCINATION COMPLICATION (Severe reaction), PYREXIA (Fever (not measured).), CHILLS (Chills) and NAUSEA (nausea). On 23-Feb-2021, MUSCULAR WEAKNESS (When she tried to get out of bed her legs would not hold her up), ASTHENIA (Weakness), DIZZINESS (Very dizzy), TREMOR (Shaking), VACCINATION COMPLICATION (Severe reaction), PYREXIA (Fever (not measured).), CHILLS (Chills) and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported Treatment medications were not reported
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Fatigue, Myalgia
Clinical narrative: Fatigue; low energy; Muscle pain; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), ASTHENIA (low energy), MYALGIA (Muscle pain) and ARTHRALGIA (joint pain) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03DL2BA) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included VITAMINS NOS and ATORVASTATIN for an unknown indication.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced FATIGUE (Fatigue), ASTHENIA (low energy), MYALGIA (Muscle pain) and ARTHRALGIA (joint pain). At the time of the report, FATIGUE (Fatigue), ASTHENIA (low energy), MYALGIA (Muscle pain) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also included Heart medication. No treatment medications were provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills) and PYREXIA (Fever). At the time of the report, CHILLS (chills) and PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: achiness; headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (achiness) and HEADACHE (headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 10-Feb-2021, the patient experienced MYALGIA (achiness) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Ache, at an unspecified dose and frequency. At the time of the report, MYALGIA (achiness) and HEADACHE (headache) outcome was unknown.            No concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling cold, Pyrexia
Clinical narrative: A spontaneous report was received from a consumer concerning a old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced  little fever/pyrexia, bones hurting/arthralgia, felt cold/feeling cold. The patient's medical history includes arthritis. No relevant concomitant medications were reported. On 10 Feb 2021, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: 016M20A) via unknown route for prophylaxis of COVID-19 infection. On an unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection. On 11 Feb 2021, the patient experienced little fever/pyrexia, bones hurting/arthralgia, felt cold/feeling cold. Treatment details included ginger tea. Action taken with mRNA-1273 in response to the events was not reported. On an unknown date the outcome of little fever/pyrexia, bones hurting/arthralgia, felt cold/feeling cold was unknown.